Incidence of invasive fungal infections in patients with chronic lymphocytic leukemia receiving ibrutinib within the Veteran's Healthcare Administration

Abstract: Purpose: Ibrutinib is a tyrosine kinase inhibitor that is increasingly prescribed in chronic lymphocytic leukemia (CLL). Invasive fungal infections (IFIs) have been …